Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Health & Fitness Stocks Positioned for Strong 2025 Growth
Health & Fitness Stocks Positioned for Strong 2025 Growth

An updated edition of the June 27, 2025, article.The health and fitness industry has grown from a niche interest into a powerhouse market, driven by a cultural shift toward healthier living. People

Is Cisco Systems (CSCO) a 'Buy' Ahead of Its Upcoming Earnings Announcement?
Is Cisco Systems (CSCO) a 'Buy' Ahead of Its Upcoming Earnings Announcement?

Tech heavyweight Cisco Systems CSCO is set to report fiscal Q4 earnings results on Wednesday after the closing bell. Cisco, a Zacks Rank #2 (Buy), has handily outperformed the market year-to-date

Realty Income vs. Simon Property: Which REIT Wins the Dividend Battle?
Realty Income vs. Simon Property: Which REIT Wins the Dividend Battle?

Income-focused investors often look to real estate investment trusts (REITs) for steady and growing dividend streams. Two of the largest and most prominent names in the sector — Realty Income

Costco (COST) Is Considered a Good Investment by Brokers: Is That True?
Costco (COST) Is Considered a Good Investment by Brokers: Is That True?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Is It Worth Investing in Analog Devices (ADI) Based on Wall Street's Bullish Views?
Is It Worth Investing in Analog Devices (ADI) Based on Wall Street's Bullish Views?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Wall Street Bulls Look Optimistic About Camtek (CAMT): Should You Buy?
Wall Street Bulls Look Optimistic About Camtek (CAMT): Should You Buy?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Schlumberger (SLB) Is Considered a Good Investment by Brokers: Is That True?
Schlumberger (SLB) Is Considered a Good Investment by Brokers: Is That True?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Vertiv (VRT) Is Considered a Good Investment by Brokers: Is That True?
Vertiv (VRT) Is Considered a Good Investment by Brokers: Is That True?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Is It Worth Investing in Micron (MU) Based on Wall Street's Bullish Views?
Is It Worth Investing in Micron (MU) Based on Wall Street's Bullish Views?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Is SkyWest (SKYW) a Buy as Wall Street Analysts Look Optimistic?
Is SkyWest (SKYW) a Buy as Wall Street Analysts Look Optimistic?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Is Citigroup (C) a Buy as Wall Street Analysts Look Optimistic?
Is Citigroup (C) a Buy as Wall Street Analysts Look Optimistic?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point
New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium

Dun & Bradstreet (DNB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Dun & Bradstreet (DNB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Dun & Bradstreet (DNB) reported $585.2 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 1.6%. EPS of $0.19 for the same period compares to $0.23 a year

TransMedics (TMDX) Recently Broke Out Above the 50-Day Moving Average
TransMedics (TMDX) Recently Broke Out Above the 50-Day Moving Average

TransMedics (TMDX) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, TMDX broke out above the 50-day moving average

Is Tutor Perini (TPC) a Buy as Wall Street Analysts Look Optimistic?
Is Tutor Perini (TPC) a Buy as Wall Street Analysts Look Optimistic?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Wall Street Analysts Think e.l.f. Beauty (ELF) Is a Good Investment: Is It?
Wall Street Analysts Think e.l.f. Beauty (ELF) Is a Good Investment: Is It?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Here's What Investors Should Expect From RADCOM's Q2 Earnings
Here's What Investors Should Expect From RADCOM's Q2 Earnings

RADCOM Ltd. (RDCM) is slated to report second-quarter 2025 results on Aug. 13, before market open.

The Zacks Consensus Estimate for revenues is $17 million, suggesting 14.9% growth from the

Reasons to Include Curtiss-Wright Stock in Your Portfolio Right Now
Reasons to Include Curtiss-Wright Stock in Your Portfolio Right Now

Curtiss-Wright Corp. CW benefits from rising commercial nuclear aftermarket sales and consistent shareholder-focused initiatives that have played a pivotal role in strengthening the company’s

Green Dot's Earnings and Revenues Surpass Estimates in Q2
Green Dot's Earnings and Revenues Surpass Estimates in Q2

Green Dot Corporation GDOT reported impressive second-quarter 2025 results, wherein both earnings and revenues beat the Zacks Consensus Estimate.

Quarterly earnings per share (excluding $1.25 from

International Markets and Lam Research (LRCX): A Deep Dive for Investors
International Markets and Lam Research (LRCX): A Deep Dive for Investors

Have you evaluated the performance of Lam Research's (LRCX) international operations during the quarter that concluded in June 2025? Considering the extensive worldwide presence of this

Xeris Biopharma Holdings, Inc. (XERS) Hits Fresh High: Is There Still Room to Run?
Xeris Biopharma Holdings, Inc. (XERS) Hits Fresh High: Is There Still Room to Run?

Have you been paying attention to shares of Xeris Biopharma (XERS)? Shares have been on the move with the stock up 32.4% over the past month. The stock hit a new 52-week high of $7.61 in the

Deciphering MKS (MKSI) International Revenue TrendsPhoto, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.theapi.app/temp/ec495607-1e17-40ee-a41d-7726313a9707.png
Deciphering MKS (MKSI) International Revenue Trends

Have you assessed how the international operations of MKS (MKSI) performed in the quarter ended June 2025? For this maker of analysis and processing equipment for semiconductor companies, possessing

Watts Water (WTS) International Revenue Performance Explored
Watts Water (WTS) International Revenue Performance Explored

Have you evaluated the performance of Watts Water's (WTS) international operations during the quarter that concluded in June 2025? Considering the extensive worldwide presence of this maker of

Puma Biotechnology, Inc. (PBYI) Soars to 52-Week High, Time to Cash Out?Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Puma Biotechnology, Inc. (PBYI) Soars to 52-Week High, Time to Cash Out?

A strong stock as of late has been Puma Biotech (PBYI). Shares have been marching higher, with the stock up 40.6% over the past month. The stock hit a new 52-week high of $5.06 in the previous

Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks

Strange but true: seniors fear death less than running out of money in retirement.

Also, retirees who have constructed a nest egg have valid justifications to be concerned, since the traditional